Figure 3.

Comparison of 0.5-year, 1-year PFS between non-CIK group and CIK group. OR, odds ratio; PFS, progression-free survival; non-CIK, non-CIK-based therapy; CIK, CIK-based therapy. The fixed effects model (Mantel-Haenszel method) was used in this analysis.

Ma et al. Experimental Hematology & Oncology 2012 1:11   doi:10.1186/2162-3619-1-11
Download authors' original image